Literature DB >> 24473832

Concepts and controversies: the 2013 American College of Cardiology/American Heart Association risk assessment and cholesterol treatment guidelines.

Seth S Martin, Roger S Blumenthal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24473832     DOI： 10.7326/M13-2805

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  15 in total

Review 1.  Impact on cognitive function-are all statins the same?

Authors:  Nishant P Shah; Kristopher J Swiger; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

Review 2.  Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines.

Authors:  Seth S Martin; Laurence S Sperling; Michael J Blaha; Peter W F Wilson; Ty J Gluckman; Roger S Blumenthal; Neil J Stone
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

3.  Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.

Authors:  Amit Pursnani; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; Udo Hoffmann
Journal:  JAMA       Date:  2015-07-14       Impact factor: 56.272

Review 4.  Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus.

Authors:  Joseph D Feuerstein; Natalia E Castillo; Mona Akbari; Edward Belkin; Jeffrey J Lewandowski; Christine M Hurley; Samuel Lloyd; Daniel A Leffler; Adam S Cheifetz
Journal:  Dig Dis Sci       Date:  2016-06-15       Impact factor: 3.199

5.  The 2013 ACC/AHA cardiovascular prevention guidelines improve alignment of statin therapy with coronary atherosclerosis as detected by coronary computed tomography angiography.

Authors:  Amit Pursnani; Thomas Mayrhofer; Maros Ferencik; Udo Hoffmann
Journal:  Atherosclerosis       Date:  2014-09-30       Impact factor: 5.162

Review 6.  Approach to Statin Use in 2016: an Update.

Authors:  P Elliott Miller; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

Review 7.  Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines.

Authors:  Miguel Cainzos-Achirica; Chintan S Desai; Libin Wang; Michael J Blaha; Francisco Lopez-Jimenez; Stephen L Kopecky; Roger S Blumenthal; Seth S Martin
Journal:  Mayo Clin Proc       Date:  2015-08-11       Impact factor: 7.616

Review 8.  The art of cardiovascular risk assessment.

Authors:  Jay Khambhati; Marc Allard-Ratick; Devinder Dhindsa; Suegene Lee; John Chen; Pratik B Sandesara; Wesley O'Neal; Arshed A Quyyumi; Nathan D Wong; Roger S Blumenthal; Laurence S Sperling
Journal:  Clin Cardiol       Date:  2018-05-10       Impact factor: 2.882

Review 9.  Regression discontinuity designs in healthcare research.

Authors:  Atheendar S Venkataramani; Jacob Bor; Anupam B Jena
Journal:  BMJ       Date:  2016-03-14

10.  Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.

Authors:  Kentaro Sakamoto; Mitsunobu Kawamura; Takahide Kohro; Masao Omura; Takayuki Watanabe; Keiko Ashidate; Toshiyuki Horiuchi; Hidehiko Hara; Nobuo Sekine; Rina Chin; Motoyoshi Tsujino; Toru Hiyoshi; Motoki Tagami; Akira Tanaka; Yasumichi Mori; Takeshi Inazawa; Tsutomu Hirano; Tsutomu Yamazaki; Teruo Shiba
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.